Ventrus executes a reverse merger with subsidiary

|By:, SA News Editor

Ventrus Biosciences (VTUS) merges with its wholly-owned subsidiary Assembly Acquisition (merger sub) and Assembly Pharmaceuticals. After the transaction, Assembly Acquisition will cease and Assembly Pharmaceuticals will survive as a wholly-owned subsidiary of Ventrus. Share of Assembly will be automatically converted into Ventrus shares at a specific exchange ratio (undisclosed).